However, as discussed above, apoM has profound effects on both VLDL/LDL metabolism and S1P that also interfere with atherosclerosis, and the net effect of apoM (if any) on cardiovascular disease (CVD) risk in humans is unresolved. This evidence concerns the gene APOM and atherosclerosis.